. 2021; 38(4): 273-285 | DOI: 10.4274/tjh.galenos.2021.2021.0007 | |||
Kronik Lenfositik Lösemili Hastalarda İbrutinib Tedavisinin Etkililiği ve Güvenilirliği: Gerçek Hayat Verilerinin Retrospektif AnaliziAnıl Tombak1, Funda Pepedil Tanrıkulu2, Salih Sertaç Durusoy3, Hüseyin Derya Dinçyürek4, Emin Kaya5, Elif Gülsüm Ümit6, İrfan Yavaşoğlu7, Özgür Mehtap8, Burak Deveci9, Mehmet Ali Özcan10, Hatice Terzi11, Müfide Okay12, Nilgün Sayınalp12, Mehmet Yılmaz3, Vahap Okan3, Alperen Kızıklı3, Ömer Özcan13, Güven Çetin13, Sinan Demircioğlu14, İsmet Aydoğdu15, Güray Saydam16, Eren Arslan Davulcu16, Gül İlhan17, Mehmet Ali Uçar18, Gülsüm Özet18, Seval Akpınar19, Burhan Turgut19, İlhami Berber5, Erdal Kurtoğlu20, Mehmet Sönmez21, Derya Selim Batur21, Rahşan Yıldırım22, Vildan Özkocaman23, Ahmet Kürşad Güneş24, Birsen Sahip25, Şehmus Ertop25, Olga Meltem Akay26, Abdülkadir Baştürk27, Mehmet Hilmi Doğu28, Aydan Akdeniz1, Ali Ünal29, Ahmet Seyhanlı30, Emel Gürkan4, Demet Çekdemir31, Burhan Ferhanoğlu321Mersin University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Mersin, Turkey2Başkent University Adana Application and Research Center, Adana, Turkey 3Gaziantep University Faculty of Medicine, Department of Hematology, Gaziantep, Turkey 4Çukurova University Faculty of Medicine, Department of Hematology, Adana, Turkey 5İnönü University Turgut Özal Medical Center, Department of Hematology, Malatya, Turkey 6Trakya University Faculty of Medicine, Department of Hematology, Edirne, Turkey 7Adnan Menderes Univercity Faculty of Medicine, Department of Hematology, Aydın, Turkey 8Kocaeli University Faculty of Medicine,Department of Hematology, Kocaeli, Turkey 9Medstar Antalya Hospital, Clinic of Hematology, Antalya, Turkey 10Dokuz Eylül University Faculty of Medicine, Department of Hematology, İzmir, Turkey 11Cumhuriyet University Faculty of Medicine, Department of Hematology, Sivas, Turkey 12Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey 13Bezmialem Vakıf University Faculty of Medicine, Department of Hematology, İstanbul, Turkey 14Necmettin Erbakan University Meram Faculty of Medicine, Department of Hematology, Konya, Turkey 15Celal Bayar University Faculty of Medicine, Department of Hematology, Manisa, Turkey 16Ege University Hospital, Clinic of Internal Medicine, Division of Hematology İzmir, Turkey 17Mustafa Kemal University Faculty of Medicine, Department of Internal Medicine, Hatay, Turkey 18Ankara Numune Training and Research Hospital, Clinic of Hematology, Ankara, Turkey 19Namık Kemal University Faculty of Medicine, Department of Hematology, Tekirdağ, Turkey 20Antalya Training and Research Hospital, Clinic of Hematology, Antalya, Turkey 21Karadeniz Technical University Faculty of Medicine, Department of Hematology, Trabzon, Turkey 22Ataturk University Faculty of Medicine, Department of Hematology, Erzurum, Turkey 23Uludağ University Faculty of Medicine, Division of Hematology, Bursa, Turkey 24Şanlıurfa Mehmet Akif İnan Training and Research Hospital, Clinic of Hematology, Şanlıurfa, Turkey 25Zonguldak Bülent Ecevit University Faculty of Medicine, Department of Hematology, Zonguldak, Turkey 26Koç University Faculty of Medicine, Department of Hematology, İstanbul, Turkey 27Konya Training and Research Hospital, Clinic of Internal Medicine, Konya, Turkey 28İstanbul Training and Research Hospital, Clinic of Hematology, İstanbul, Turkey 29Erciyes University Faculty of Medicine, Department of Internal Medicine, Kayseri, Turkey 30Ege University Faculty of Medicine, Department of Hematology, İzmir, Turkey 31Anadolu Medical Center, Bone Marrow Transplantation Center, Department of Hematology, Kocaeli, Turkey 32İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Department of Internal Medicine Section of Haematology, İstanbul, Turkey Amaç: Kronik lenfositik lösemi hastalarında tek ajan ibrutinib tedavisinin etkinliğini, güvenliğini ve sağkalım sonuçlarını geriye dönük olarak değerlendirmek. Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life DataAnıl Tombak1, Funda Pepedil Tanrıkulu2, Salih Sertaç Durusoy3, Hüseyin Derya Dinçyürek4, Emin Kaya5, Elif Gülsüm Ümit6, İrfan Yavaşoğlu7, Özgür Mehtap8, Burak Deveci9, Mehmet Ali Özcan10, Hatice Terzi11, Müfide Okay12, Nilgün Sayınalp12, Mehmet Yılmaz3, Vahap Okan3, Alperen Kızıklı3, Ömer Özcan13, Güven Çetin13, Sinan Demircioğlu14, İsmet Aydoğdu15, Güray Saydam16, Eren Arslan Davulcu16, Gül İlhan17, Mehmet Ali Uçar18, Gülsüm Özet18, Seval Akpınar19, Burhan Turgut19, İlhami Berber5, Erdal Kurtoğlu20, Mehmet Sönmez21, Derya Selim Batur21, Rahşan Yıldırım22, Vildan Özkocaman23, Ahmet Kürşad Güneş24, Birsen Sahip25, Şehmus Ertop25, Olga Meltem Akay26, Abdülkadir Baştürk27, Mehmet Hilmi Doğu28, Aydan Akdeniz1, Ali Ünal29, Ahmet Seyhanlı30, Emel Gürkan4, Demet Çekdemir31, Burhan Ferhanoğlu321Mersin University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Mersin, Turkey2Başkent University Adana Application and Research Center, Adana, Turkey 3Gaziantep University Faculty of Medicine, Department of Hematology, Gaziantep, Turkey 4Çukurova University Faculty of Medicine, Department of Hematology, Adana, Turkey 5İnönü University Turgut Özal Medical Center, Department of Hematology, Malatya, Turkey 6Trakya University Faculty of Medicine, Department of Hematology, Edirne, Turkey 7Adnan Menderes Univercity Faculty of Medicine, Department of Hematology, Aydın, Turkey 8Kocaeli University Faculty of Medicine,Department of Hematology, Kocaeli, Turkey 9Medstar Antalya Hospital, Clinic of Hematology, Antalya, Turkey 10Dokuz Eylül University Faculty of Medicine, Department of Hematology, İzmir, Turkey 11Cumhuriyet University Faculty of Medicine, Department of Hematology, Sivas, Turkey 12Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey 13Bezmialem Vakıf University Faculty of Medicine, Department of Hematology, İstanbul, Turkey 14Necmettin Erbakan University Meram Faculty of Medicine, Department of Hematology, Konya, Turkey 15Celal Bayar University Faculty of Medicine, Department of Hematology, Manisa, Turkey 16Ege University Hospital, Clinic of Internal Medicine, Division of Hematology İzmir, Turkey 17Mustafa Kemal University Faculty of Medicine, Department of Internal Medicine, Hatay, Turkey 18Ankara Numune Training and Research Hospital, Clinic of Hematology, Ankara, Turkey 19Namık Kemal University Faculty of Medicine, Department of Hematology, Tekirdağ, Turkey 20Antalya Training and Research Hospital, Clinic of Hematology, Antalya, Turkey 21Karadeniz Technical University Faculty of Medicine, Department of Hematology, Trabzon, Turkey 22Ataturk University Faculty of Medicine, Department of Hematology, Erzurum, Turkey 23Uludağ University Faculty of Medicine, Division of Hematology, Bursa, Turkey 24Şanlıurfa Mehmet Akif İnan Training and Research Hospital, Clinic of Hematology, Şanlıurfa, Turkey 25Zonguldak Bülent Ecevit University Faculty of Medicine, Department of Hematology, Zonguldak, Turkey 26Koç University Faculty of Medicine, Department of Hematology, İstanbul, Turkey 27Konya Training and Research Hospital, Clinic of Internal Medicine, Konya, Turkey 28İstanbul Training and Research Hospital, Clinic of Hematology, İstanbul, Turkey 29Erciyes University Faculty of Medicine, Department of Internal Medicine, Kayseri, Turkey 30Ege University Faculty of Medicine, Department of Hematology, İzmir, Turkey 31Anadolu Medical Center, Bone Marrow Transplantation Center, Department of Hematology, Kocaeli, Turkey 32İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Department of Internal Medicine Section of Haematology, İstanbul, Turkey Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Anıl Tombak, Funda Pepedil Tanrıkulu, Salih Sertaç Durusoy, Hüseyin Derya Dinçyürek, Emin Kaya, Elif Gülsüm Ümit, İrfan Yavaşoğlu, Özgür Mehtap, Burak Deveci, Mehmet Ali Özcan, Hatice Terzi, Müfide Okay, Nilgün Sayınalp, Mehmet Yılmaz, Vahap Okan, Alperen Kızıklı, Ömer Özcan, Güven Çetin, Sinan Demircioğlu, İsmet Aydoğdu, Güray Saydam, Eren Arslan Davulcu, Gül İlhan, Mehmet Ali Uçar, Gülsüm Özet, Seval Akpınar, Burhan Turgut, İlhami Berber, Erdal Kurtoğlu, Mehmet Sönmez, Derya Selim Batur, Rahşan Yıldırım, Vildan Özkocaman, Ahmet Kürşad Güneş, Birsen Sahip, Şehmus Ertop, Olga Meltem Akay, Abdülkadir Baştürk, Mehmet Hilmi Doğu, Aydan Akdeniz, Ali Ünal, Ahmet Seyhanlı, Emel Gürkan, Demet Çekdemir, Burhan Ferhanoğlu. Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data. . 2021; 38(4): 273-285 Sorumlu Yazar: Anıl Tombak |
|